Company Filing History:
2 out of 233 
1 out of 832,812 Years Active: 2003-2007
Title: Wayne Kelln: Innovator in Colon Cancer Detection
Introduction
Wayne Kelln is a notable inventor based in Loma Linda, California. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colon cancer. With a total of 3 patents, his work has the potential to impact cancer screening methods significantly.
Latest Patents
Wayne Kelln's latest patents include a method of detecting colon cancer through an immunological assay and kit. This innovative approach involves extracting fecal glycoproteins from individual samples while maintaining their immunogenicity. The purified fecal glycoproteins are then reacted with antibodies to the Colon and Ovarian Tumor Antigen (COTA). This mucin antigen is specifically present in colorectal cancer tissue and absent in normal colons. The amount of COTA in the fecal sample is determined and used to indicate the presence of colon cancer.
Career Highlights
Throughout his career, Wayne Kelln has worked with Loma Linda University, where he has contributed to research and development in medical diagnostics. His expertise in immunological assays has positioned him as a key figure in the fight against colon cancer.
Collaborations
Wayne has collaborated with notable colleagues such as Keshab D Pant and John D McCracken. Their combined efforts have further advanced the research in cancer detection methodologies.
Conclusion
Wayne Kelln's innovative work in colon cancer detection exemplifies the importance of research and development in medical diagnostics. His contributions have the potential to improve cancer screening processes and ultimately save lives.